The Judicial Panel on Multidistrict Litigation recently announced that GranuFlo and NaturaLyte claims will be centralized in Massachusetts federal court under the leadership of Judge Douglas P. Woodlock. While there was no dispute over the need for an MDL for this litigation, there was a dispute over where the MDL should be located. Several jurisdictions were considered, including the Southern District of Mississippi, the District of New Jersey, and the Eastern District of New York to name a few. Ultimately, the panel determined that Massachusetts would serve the convenience of the parties and witnesses and promote the just and efficient conduct of this litigation. The manufacturer of GranuFlo, Fresenius, is headquartered in Waltham, Mass., and given that there were already multiple GranuFlo cases pending in Massachusetts state court, it was presumed that locating the MDL in the state’s federal court system would help facilitate coordination with the pending state litigation.
GranuFlo and NaturaLyte are products used in the dialysis process. These products were recalled by the FDA on June 17, 2012. The use of these products is linked to metabolic alkalosis, a condition in which the body’s pH levels are elevated beyond the normal range. As a result, serious injury can occur, including cardiopulmonary arrest and sudden cardiac death. For more information about GranuFlo, please contact Frank Woodson or Matt Munson, lawyers in our firm’s Mass Torts Section, at 800-898-2034 or by email at Frank.Woodson@beasleyallen.com or Matt.Munson@beasleyallen.com.
Source: JPML filing
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.